Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation

MS. Spence, J. Baan, F. Iacovelli, GL. Martinelli, DF. Muir, F. Saia, AS. Bortone, CG. Densem, CG. Owens, F. van der Kley, M. Vis, MS. van Mourik, G. Costa, L. Sykorova, CM. Lüske, C. Deutsch, J. Kurucova, M. Thoenes, P. Bramlage, C. Tamburino,...

. 2020 ; 9 (15) : e016990. [pub] 20200725

Language English Country Great Britain

Document type Journal Article, Multicenter Study, Observational Study, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc21012288

Background Despite the availability of guidelines for the performance of transcatheter aortic valve implantation (TAVI), current treatment pathways vary between countries and institutions, which impact on the mean duration of postprocedure hospitalization. Methods and Results This was a prospective, multicenter registry of 502 patients to validate the appropriateness of discharge timing after transfemoral TAVI, using prespecified risk criteria from FAST-TAVI (Feasibility and Safety of Early Discharge After Transfemoral [TF] Transcatheter Aortic Valve Implantation), based on hospital events within 1-year after discharge. The end point-a composite of all-cause mortality, vascular access-related complications, permanent pacemaker implantation, stroke, cardiac rehospitalization, kidney failure, and major bleeding-was reached in 27.0% of patients (95% CI, 23.3-31.2) within 1 year after intervention; 7.5% (95% CI, 5.5-10.2) had in-hospital complications before discharge and 19.6% (95% CI, 16.3-23.4) within 1 year after discharge. Overall mortality within 1 year after discharge was 7.3% and rates of cardiac rehospitalization 13.5%, permanent pacemaker implantation 4.2%, any stroke 1.8%, vascular-access-related complications 0.7%, life-threatening bleeding 0.7%, and kidney failure 0.4%. Composite events within 1 year after discharge were observed in 18.8% and 24.3% of patients with low risk of complications/early (≤3 days) discharge and high risk and discharged late (>3 days) (concordant discharge), respectively. Event rate in patients with discordant discharge was 14.3% with low risk but discharged late and increased to 50.0% in patients with high risk but discharged in ≤3 days. Conclusions The FAST-TAVI risk assessment provides a tool for appropriate, risk-based discharge that was validated with the 1-year event rate after transfemoral TAVI. Registration URL: https://www.ClinicalTrials.gov; Unique identifier: NCT02404467.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21012288
003      
CZ-PrNML
005      
20210507103343.0
007      
ta
008      
210420s2020 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1161/JAHA.120.016990 $2 doi
035    __
$a (PubMed)32715844
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Spence, Mark S $u Cardiology Department Royal Victoria Hospital Belfast United Kingdom
245    10
$a Prespecified Risk Criteria Facilitate Adequate Discharge and Long-Term Outcomes After Transfemoral Transcatheter Aortic Valve Implantation / $c MS. Spence, J. Baan, F. Iacovelli, GL. Martinelli, DF. Muir, F. Saia, AS. Bortone, CG. Densem, CG. Owens, F. van der Kley, M. Vis, MS. van Mourik, G. Costa, L. Sykorova, CM. Lüske, C. Deutsch, J. Kurucova, M. Thoenes, P. Bramlage, C. Tamburino, M. Barbanti
520    9_
$a Background Despite the availability of guidelines for the performance of transcatheter aortic valve implantation (TAVI), current treatment pathways vary between countries and institutions, which impact on the mean duration of postprocedure hospitalization. Methods and Results This was a prospective, multicenter registry of 502 patients to validate the appropriateness of discharge timing after transfemoral TAVI, using prespecified risk criteria from FAST-TAVI (Feasibility and Safety of Early Discharge After Transfemoral [TF] Transcatheter Aortic Valve Implantation), based on hospital events within 1-year after discharge. The end point-a composite of all-cause mortality, vascular access-related complications, permanent pacemaker implantation, stroke, cardiac rehospitalization, kidney failure, and major bleeding-was reached in 27.0% of patients (95% CI, 23.3-31.2) within 1 year after intervention; 7.5% (95% CI, 5.5-10.2) had in-hospital complications before discharge and 19.6% (95% CI, 16.3-23.4) within 1 year after discharge. Overall mortality within 1 year after discharge was 7.3% and rates of cardiac rehospitalization 13.5%, permanent pacemaker implantation 4.2%, any stroke 1.8%, vascular-access-related complications 0.7%, life-threatening bleeding 0.7%, and kidney failure 0.4%. Composite events within 1 year after discharge were observed in 18.8% and 24.3% of patients with low risk of complications/early (≤3 days) discharge and high risk and discharged late (>3 days) (concordant discharge), respectively. Event rate in patients with discordant discharge was 14.3% with low risk but discharged late and increased to 50.0% in patients with high risk but discharged in ≤3 days. Conclusions The FAST-TAVI risk assessment provides a tool for appropriate, risk-based discharge that was validated with the 1-year event rate after transfemoral TAVI. Registration URL: https://www.ClinicalTrials.gov; Unique identifier: NCT02404467.
650    _2
$a lidé $7 D006801
650    12
$a propuštění pacienta $7 D010351
650    _2
$a pooperační komplikace $x epidemiologie $7 D011183
650    _2
$a prospektivní studie $7 D011446
650    12
$a registrace $7 D012042
650    _2
$a transkatetrální implantace aortální chlopně $x statistika a číselné údaje $7 D065467
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a pozorovací studie $7 D064888
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Baan, Jan $u Department of Cardiology Amsterdam UMCUniversity of Amsterdam The Netherlands
700    1_
$a Iacovelli, Fortunato $u Cardiology Department Department of Advanced Biomedical Sciences University of Naples Italy $u Cardiac Surgery Department Clinica San Gaudenzio Novara Italy
700    1_
$a Martinelli, Gian Luca $u Cardiology Department "Montevergine" Clinic Mercogliano Italy
700    1_
$a Muir, Douglas F $u Cardiothoracic Division The James Cook University Hospital Middlesbrough United Kingdom
700    1_
$a Saia, Francesco $u Cardiovascular and Thoracic Department S. Orsola-Malpighi University Hospital Bologna Italy
700    1_
$a Bortone, Alessandro Santo $u Cardiology Department University of Bari "Aldo Moro" Bari Italy
700    1_
$a Densem, Cameron G $u Cardiology Department Papworth Hospital Cambridge United Kingdom
700    1_
$a Owens, Colum G $u Cardiology Department Royal Victoria Hospital Belfast United Kingdom
700    1_
$a van der Kley, Frank $u Cardiology Department Leiden University Medical Center Leiden The Netherlands
700    1_
$a Vis, Marije $u Department of Cardiology Amsterdam UMCUniversity of Amsterdam The Netherlands
700    1_
$a van Mourik, Martijn S $u Department of Cardiology Amsterdam UMCUniversity of Amsterdam The Netherlands
700    1_
$a Costa, Giuliano $u Catania Division of Cardiology Policlinico-Vittorio Emanuele HospitalUniversity of Catania Italy
700    1_
$a Sykorova, Lenka $u Edwards-Lifesciences Prague Czech Republic
700    1_
$a Lüske, Claudia M $u Institute for Pharmacology and Preventive Medicine Cloppenburg Germany
700    1_
$a Deutsch, Cornelia $u Institute for Pharmacology and Preventive Medicine Cloppenburg Germany
700    1_
$a Kurucova, Jana $u Edwards-Lifesciences Prague Czech Republic
700    1_
$a Thoenes, Martin $u Edwards-Lifesciences Nyon Switzerland
700    1_
$a Bramlage, Peter $u Institute for Pharmacology and Preventive Medicine Cloppenburg Germany
700    1_
$a Tamburino, Corrado $u Catania Division of Cardiology Policlinico-Vittorio Emanuele HospitalUniversity of Catania Italy
700    1_
$a Barbanti, Marco $u Catania Division of Cardiology Policlinico-Vittorio Emanuele HospitalUniversity of Catania Italy
773    0_
$w MED00188127 $t Journal of the American Heart Association $x 2047-9980 $g Roč. 9, č. 15 (2020), s. e016990
856    41
$u https://pubmed.ncbi.nlm.nih.gov/32715844 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20210420 $b ABA008
991    __
$a 20210507103341 $b ABA008
999    __
$a ok $b bmc $g 1650618 $s 1132667
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 9 $c 15 $d e016990 $e 20200725 $i 2047-9980 $m Journal of the American Heart Association $n J Am Heart Assoc $x MED00188127
LZP    __
$a Pubmed-20210420

Find record

Citation metrics

Archiving options